February 21, 2024 12:59 PM EST
FDA+
Law

SCO­TUS jus­tices hint at un­cer­tain fu­ture of Chevron doc­trine in tan­gen­tial case

Lia DeGroot

Two loom­ing de­ci­sions at the Supreme Court — one on the FDA’s reg­u­la­tion of a com­mon­ly used abor­tion drug and an­oth­er on the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bridge­Bio ends de­vel­op­ment of gene ther­a­py for adren­al gland dis­or­der

Sanofi, Re­gen­eron to re­file Dupix­ent for skin con­di­tion af­ter new study win

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

Ra­di­ant Bio snags $35M for an­ti­body plat­form, with GSK and Re­gen­eron part­ner­ships

Novo's oral amy­cretin could lead to more weight loss be­yond 12 weeks, ac­cord­ing to ear­ly-stage tri­al

GSK dis­con­tin­ues her­pes ther­a­peu­tic vac­cine af­ter Phase 2 dis­ap­point­ment

A service from the Financial Times